Big Pharma Finds a Home on Campus

As drug companies scale back spending on R&D, academic research takes on financial risk

Joon Powell for The Chronicle

P. Jeffrey Conn co-directs Vanderbilt U.’s Center for Neuroscience Drug Discovery, which has attracted top researchers from pharmaceutical companies.
July 24, 2011

P. Jeffrey Conn left a full professorship for a job in Big Pharma 11 years ago because he saw no path in academe to turn his novel idea for treating Parkinson's disease into an actual drug. Now he and a corps of scientists are closing in on a…

This content is available exclusively to Chronicle subscribers